{"id":"W4402535093","doi":"10.1016/s0140-6736(24)01808-7","title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trial","year":2024,"lang":"en","type":"article","venue":"The Lancet","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":161,"is_retracted":false,"has_abstract":false,"ca_institutions":"McGill University Health Centre","funders":"Meso Scale Diagnostics","keywords":"Pembrolizumab; Medicine; Placebo; Chemoradiotherapy; Cervical cancer; Internal medicine; Oncology; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001631163,0.001573239,0.003682735,0.0005175277,0.0004509971,0.0008826258,0.0009864208,0.002347156,0.00948695],"category_scores_gemma":[0.001695748,0.0006920337,0.002521001,0.0004245105,0.001204109,0.001218693,0.0003690101,0.003396751,0.001495279],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006636588,"about_ca_system_score_gemma":0.0008112836,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001207791,"about_ca_topic_score_gemma":0.002761466,"domain_scores_codex":[0.999355,0.0003179558,0.0000469783,0.000137221,0.00003891219,0.0001039306],"domain_scores_gemma":[0.9994377,0.0002245409,0.0001233094,0.00004374751,0.0000288189,0.000141782],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9832844,0.002159395,0.000115127,0.0009804536,0.0008218206,0.00002077195,0.00002640474,0.0001370704,0.001597151,0.00008355608,0.0005835049,0.01019028],"study_design_scores_gemma":[0.9702373,0.02797541,0.0005749443,0.00004698736,0.0003557098,0.0000142483,0.00001211744,0.0001358055,0.000179824,0.00009449871,0.0003644976,0.000008769847],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952173,0.02550504,0.001898019,0.001580184,0.002770009,0.007770456,0.002021933,0.0004387239,0.005842559],"genre_scores_gemma":[0.9736545,0.007762494,0.002142643,0.00187768,0.0007293597,0.005955858,0.001012446,0.00004664624,0.006818382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00948695,"threshold_uncertainty_score":0.03173697,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04154028441403743,"score_gpt":0.3431262730643566,"score_spread":0.3015859886503192,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}